LEXX · Forms 3, 4, 5
Insider trades at Lexaria Bioscience Corp.
No open-market insider buys or sells at Lexaria Bioscience Corp. in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for Lexaria Bioscience Corp. (LEXX) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for Lexaria Bioscience Corp. in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Christopher Bunka | Director | Gift | 100,000 | Form 4 | |||
| Christopher Bunka | Director | Buy | 11,900 | $0.91 | $11K | Form 4 | |
| Christopher Bunka | Director | Buy | 15,600 | $0.92 | $14K | Form 4 | |
| William Edward McKechnie | Director | Buy | 5,000 | $0.91 | $5K | Form 4 | |
| John Martin Docherty | President & CSO | Buy | 5,376 | $0.93 | $5K | Form 4 | |
| Vanessa Carle | Secretary | Buy | 750 | $0.91 | $683 | Form 4 | |
| Richard Christopher | Chief Executive Officer | Buy | 15,000 | $0.91 | $14K | Form 4 | |
| Richard Christopher | Chief Executive Officer | Options or other derivatives | Form 4 | ||||
| Christopher Bunka | Director | Options or other derivatives | Form 4 | ||||
| Vanessa Carle | Secretary | Options or other derivatives | Form 4 | ||||
| John Martin Docherty | President | Options or other derivatives | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.